DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Van Gaal LF, Scheen AJ, Rissanen AM, Rössner S, Hanotin C, Ziegler O. ; RIO-Europe Study Group.
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
Eur Heart J 2008;
29 (14) 1761-1771
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.